Edwards Lifesciences (NYSE:EW) today announced its plans for significant growth as a purely structural heart company in 2025.

ShiraTronics announced that it initiated its FDA investigational device exemption (IDE) pivotal trial for its neuromodulation ...

Withings announced that it received approximately $22.5 million in investment and support for a new initiative from the ...

Zimmer Biomet (NYSE:ZBH) announced today that it received FDA 510(k) clearance for its Persona SoluTion porous plasma spray ...

A hospital in Texas announced that its electrophysiologists completed the first U.S. cases with the Medtronic (NYSE:MDT) ...